Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan crossover study in coronary slow flow phenomenon
ACTRN12608000236392Phase 3Recruiting
- Sponsor
- Central Northern Adelaide Health Service
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bosentan in Slow Coronary Flow (SCF) (2 arms), sponsored by Central Northern Adelaide Health Service. Primary endpoint: Angina frequency. Started May 2007; status: recruiting.
02
Drugs
bosentan
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on ACTRN12608000236392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000236392.